Targeting serum response factor as a novel therapeutic approach for triple-negative breast cancer.

e12560Background: Triple negative breast cancer (TNBC) is an aggressive form of breast cancer (BC) which lacks estrogen receptor, progesterone receptor and HER2 amplification. Due to the fact that ...